29 pending office actions • 16 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19363223 | Untitled | Morphosys GmbH | PAK, MICHAEL D | 1674 | Non-Final OA | |
| 18599832 | METHOD FOR ATTENUATING NEUROINFLAMMATION, AMYLOIDOPATHY AND TAUOPATHY | The Trustees of Dartmouth College | COUGHLIN, MATTHEW P | 1626 | Non-Final OA | Mar 08, 2024 |
| 18541691 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS | St. Jude Children's Research Hospital | VALENROD, YEVGENY | 1628 | Non-Final OA | Dec 15, 2023 |
| 18532345 | CLOSE-PACK, HIGH-ASPECT-RATIO CAMERA TRIPOD | Peak Design | GARFT, CHRISTOPHER | 3632 | Non-Final OA | Dec 07, 2023 |
| 18502249 | COMPOSITIONS AND METHODS FOR PRODUCING NON-HUMAN TISSUE ENGINEERED MEAT PRODUCTS | Myos Corp. | BERTOGLIO, VALARIE E | 1632 | Non-Final OA | Nov 06, 2023 |
| 18500470 | MOBILE DEVICE MOUNTING SYSTEM | Peak Design | DUCKWORTH, BRADLEY | 3632 | Final Rejection | Nov 02, 2023 |
| 18464374 | CRISPR/CAS SYSTEM AND METHOD FOR GENOME EDITING AND MODULATING TRANSCRIPTION | The Board Of Trustees Of The University Of Illinois | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Sep 11, 2023 |
| 18280531 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA | Arizona Board of Regents | RAO, PADMAJA S | 1627 | Non-Final OA | Sep 06, 2023 |
| 18268032 | BURKHOLDERIA VACCINES AND THERAPEUTICS | UNIVERSITY OF HAWAII | MORGAN, BAILEY MICHELLE | 1645 | Non-Final OA | Jun 16, 2023 |
| 18307253 | TOPICAL FORMULATIONS | Proveda Corporation | KETCHAM, KAREN A | 1614 | Non-Final OA | Apr 26, 2023 |
| 18246052 | NOVEL HUMAN ANTIBODIES BINDING TO HUMAN CD3 EPSILON | Morphosys GmbH | LU, CHENG | 1642 | Non-Final OA | Mar 21, 2023 |
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | St. Jude Children's Research Hospital | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Mar 14, 2023 |
| 18178736 | METHODS AND MICROFLUIDIC DEVICE FOR PRODUCING EXTRACELLULAR VESICLES | The Board Of Trustees Of The University Of Illinois | SPENCE, JENNIFER SUZANNE | 1633 | Non-Final OA | Mar 06, 2023 |
| 18043136 | IN SITU CELL BIOREACTOR AND DELIVERY SYSTEM AND METHODS OF USING THE SAME | The Board Of Trustees Of The University Of Illinois | WHATLEY, BENJAMIN R | 1798 | Final Rejection | Feb 27, 2023 |
| 18043095 | ALGINATE-COATED MESENCHYMAL STROMAL AND PROGENITOR CELLS AND METHODS FOR USING THE SAME | The Board Of Trustees Of The University Of Illinois | CONNORS, ALEXANDRA F | 1634 | Non-Final OA | Feb 27, 2023 |
| 18042015 | COMPOSITIONS AND METHOD FOR TREATING THALASSEMIA | St. Jude Children's Research Hospital | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Feb 17, 2023 |
| 18041873 | Use of Amylase or Maltose to Treat or Prevent Neurodegeneration | St. Jude Children's Research Hospital | O'NEILL, MARISOL ANN | 1633 | Final Rejection | Feb 16, 2023 |
| 17927038 | Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations | St. Jude Children's Research Hospital | PYLA, EVELYN Y | 1633 | Non-Final OA | Nov 22, 2022 |
| 17923070 | Hypoimmunogenic Cells and Uses Thereof in Immune Responses | Rxcell Inc. | HUYNH, PHUONG N | 1641 | Non-Final OA | Nov 03, 2022 |
| 17919622 | SYSTEM AND METHOD FOR MICRODIALYSIS FOR IN-VITRO RELEASE TESTING OF DOSAGE FORMS | Ortiv-Q3 Research Pvt. Ltd. | HERBERT, MADISON TAYLOR | 1758 | Non-Final OA | Oct 18, 2022 |
| 17801907 | RECOMBINANT FIBCD1 AND USE THEROF IN THE TREATMENT OF MUSCLE ATROPHY | St. Jude Children's Research Hospital | WHITE, ASHLEY TAYLOR | 1653 | Final Rejection | Aug 24, 2022 |
| 17778138 | PENTAPEPTIDE AND METHODS OF USE THEREOF | The Board Of Trustees Of The University Of Illinois | COFFA, SERGIO | 1658 | Non-Final OA | May 19, 2022 |
| 17777385 | METHOD TO INCREASE ANTIBODY YIELD DURING ION EXCHANGE CHROMATOGRAPHY | Morphosys GmbH | MCCOLLUM, ANDREA K | 1674 | Non-Final OA | May 17, 2022 |
| 17777366 | ELUATE COLLECTION DURING ANTIBODY CHROMATOGRAPHY | Morphosys GmbH | PAK, MICHAEL D | 1674 | Non-Final OA | May 17, 2022 |
| 17774723 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | UNIVERSITY OF HAWAII | CHENG, KAREN | 1623 | Non-Final OA | May 05, 2022 |
| 17628353 | COMPOSITION AND METHOD FOR PROMOTING WOUND HEALING | The Board Of Trustees Of The University Of Illiois | NIEBAUER, RONALD T | 1658 | Non-Final OA | Jan 19, 2022 |
| 17550051 | Use of FOXP3 Enhancers to Modulate Regulatory T Cells | St. Jude Children's Research Hospital | WILSON, MICHAEL C | 1638 | Final Rejection | Dec 14, 2021 |
| 17616279 | KIT AND METHOD FOR ANALYZING SINGLE T CELLS | St. Jude Children's Research Hospital | TURPIN, ZACHARY MARK | 1682 | Non-Final OA | Dec 03, 2021 |
| 17433900 | ORALLY INGESTED COMPOSITION FOR IMPROVING SLEEP | Wellnas.Co., Ltd. | CHICKS, ASHLI ARIANA | 1626 | Non-Final OA | Aug 25, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial